Updated · AI-assisted evidence analysis
Advanced Joint Care Chew for Dogs Review 2026: What Does the Evidence Show?
Some ingredients have dog research; no trial of this chew found — Overhyped
-
"Green-lipped mussel helps joints"
Placebo-controlled dog trials mostly favoured mussel products. One 45-dog trial beat placebo but trailed carprofen. A mussel-curcumin blend did not beat placebo on owner scores. Products and doses differ from this chew.
Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). → · Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. → · The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. → -
"Omega-3 supports hips, joints and a normal inflammatory response"
Dogs with osteoarthritis improved on EPA+DHA in a placebo-controlled trial at 69 mg/kg/day. This chew lists 110 mg total omega-3 per chew (9.7 to 55 mg/kg by size band), below that studied amount.
A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. → · Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. → -
"Glucosamine and chondroitin support cartilage and lubrication"
Evidence is thin and conflicts. One 35-dog trial had no placebo group. A dog-only review called the evidence limited and conflicting. A 2022 meta-analysis that pooled dogs and cats reported a very marked non-effect of chondroitin-glucosamine products on pain; its dog-only results were not separated in the text reviewed. No trial measured joint lubrication.
Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. → · A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. → · Glucosamine and chondroitin use in canines for osteoarthritis: A review. → -
"MSM and Boswellia back up the formula"
No dog MSM results were found in the retrieved text. Boswellia appeared only in an uncontrolled trial and in multi-ingredient products, at amounts that cannot be matched to the 40 mg per chew on this label.
Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. → · Effects of a feed supplement, containing undenatured type II collagen (UC II®) and Boswellia Serrata, in the management of mild/moderate mobility disorders in dogs: A randomized, double-blind, placebo controlled, cross-over study. → · Efficacy of a joint supplement containing eggshell membrane among other ingredients to improve the mobility of dogs with osteoarthritis: a multicenter double-blind randomized placebo-controlled study. →
Claims vs Evidence
4 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.
"Supports canine mobility, comfort and joint flexibility"
Stretch
Mussel has real but uneven dog trial support, and Boswellia only appears in combination products or an uncontrolled trial. Glucosamine and chondroitin are weak, MSM has no dog evidence found, and omega-3 is below the studied amount. No exact-product trial was found.
Green-lipped mussel vs placebo vs carprofen
Randomized, double-controlled, double-blinded trial · ingredient
More dogs improved than on placebo for vet-assessed mobility, owner chronic pain index and pain VAS (P = 0.031, 0.025, 0.011). Less effective than carprofen.
Limitations: Abstract only; product and dose differ from this chew; effect sizes unavailable.
- Species
- dog
- Participants / condition
- 45 dogs with chronic pain and radiographic osteoarthritis who completed the trial
- Formulation
- Green-lipped mussel preparation (not the PetLabCo chew)
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 8 weeks, evaluated at 4-week intervals
- Funding / conflicts
- Not reported in the abstract
Mussel plus krill oil vs placebo, NSAID
Blinded, block-randomized, placebo-controlled trial · different formulation
At 6 weeks, change in peak vertical force and orthopedic scores were significantly better than placebo in the EAB-277 group and the meloxicam group.
Limitations: Product also contains krill oil; short duration; not this formulation.
- Species
- dog
- Participants / condition
- 101 pet dogs with hip osteoarthritis pain
- Formulation
- Green-lipped mussel plus krill oil extracts (EAB-277), a branded product
- Studied amount, not dosing advice
- Not reported in the retrieved text
- Duration
- 6 weeks
- Funding / conflicts
- Funded by Pharmalink International Ltd; authors declared no conflict; funder said not involved in design or analysis.
Mussel, curcumin, blackcurrant supplement
Double-blinded, randomized, crossover, placebo-controlled trial · different formulation
Vet COAST score improved from baseline but not versus placebo. No differences on owner pain index or force plate. Authors called effects partial.
Limitations: Small sample; several non-responders; different blend.
- Species
- dog
- Participants / condition
- 32 client-owned dogs with mild to moderate osteoarthritis (cat results excluded)
- Formulation
- Green-lipped mussel, curcumin and blackcurrant leaf extract blend
- Studied amount, not dosing advice
- Not reported in the retrieved text
- Duration
- 16 weeks in dogs
- Funding / conflicts
- Not reported in the retrieved text
Undenatured collagen plus Boswellia chew
Randomized, double-blind, placebo-controlled crossover · different formulation
Owner-rated mobility impairment improved by 4 weeks with the supplement.
Limitations: Small sample; Boswellia cannot be separated from collagen.
- Species
- dog
- Participants / condition
- 17 dogs with mild/moderate osteoarthritis (of 60 screened)
- Formulation
- Supplement chew with undenatured type II collagen and Boswellia serrata
- Studied amount, not dosing advice
- 1 chew per day; per-chew Boswellia amount not reported in abstract
- Duration
- 8 weeks per period, 4-week washout
- Funding / conflicts
- Funded by Vetoquinol SA; a Vetoquinol employee took part in design, monitoring and manuscript review.
Multi-ingredient joint supplement with Boswellia and krill omega-3
Multicenter, double-blind, randomized, placebo-controlled trial · different formulation
Several measures improved over time in the supplement group; in placebo dogs CBPI pain interference and LOAD also improved. The only between-group difference reported was CBPI pain interference (p = 0.009).
Limitations: Abstract only; Boswellia and omega-3 cannot be separated from the other ingredients; between-group difference limited to one measure.
- Species
- dog
- Participants / condition
- 52 dogs with confirmed osteoarthritis enrolled; 46 completed (22 supplement, 24 placebo)
- Formulation
- Supplement with eggshell membrane, krill meal with omega-3 fatty acids, Haematococcus pluvialis (astaxanthin), hyaluronic acid and a Boswellia serrata extract
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 90 days
- Funding / conflicts
- Not reported in the abstract
Boswellia resin, open-label
Open multicentre trial, before and after treatment, no control group · ingredient
Overall efficacy in 71% of 24 eligible dogs at 2 weeks; reduced lameness, pain and stiffness at 6 weeks.
Limitations: No placebo; open label; extract differs from this chew.
- Species
- dog
- Participants / condition
- 29 dogs with chronic joint and spinal disease in Switzerland; 25 with radiographic osteoarthritis
- Formulation
- Boswellia serrata resin extract (BSB108)
- Studied amount, not dosing advice
- 400 mg per 10 kg body weight once daily
- Duration
- 6 weeks
- Funding / conflicts
- Not reported in the abstract
"Supports healthy cartilage and joint lubrication and helps with occasional joint stiffness and discomfort"
Stretch
This rests on glucosamine, chondroitin and MSM. The dog evidence for glucosamine and chondroitin is limited and conflicting, a pooled dog-and-cat meta-analysis (pmid36142319, not used as a dog-only row) reported a very marked non-effect on pain, and no dog MSM data was found. No retrieved study measured joint lubrication.
Glucosamine HCl + chondroitin vs carprofen
Randomized, double-blind, positive-controlled multicentre trial (no placebo group) · ingredient
Pain, weight-bearing and severity scores improved by day 70 (P<0.001); slower onset than carprofen.
Limitations: No placebo; subjective vet scoring; abstract only.
- Species
- dog
- Participants / condition
- 35 dogs with confirmed hip or elbow osteoarthritis
- Formulation
- Glucosamine hydrochloride and chondroitin sulfate combination (not the PetLabCo chew)
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 70 days of treatment, reassessed at day 98
- Funding / conflicts
- Not reported in the abstract
Glucosamine and chondroitin in canine OA
Narrative literature review · ingredient
Called the evidence limited and conflicting, with few well-designed veterinary studies.
Limitations: Abstract only; no pooled analysis.
- Species
- dog
- Participants / condition
- Dogs with osteoarthritis across reviewed studies
- Formulation
- Glucosamine HCl and chondroitin sulfate
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- Not reported in abstract
- Funding / conflicts
- Not reported in the abstract
"Supports hip and joint health, muscular strength and a normal inflammatory response"
Stretch
Marine omega-3 has dog evidence for osteoarthritis signs, but this chew provides less than the amount in the placebo-controlled trial. No retrieved study tested muscular strength.
EPA and DHA vs placebo oil
Prospective, randomized, double-blind, placebo-controlled trial · ingredient
Discomfort, lameness and joint severity improved versus placebo at day 84; no major side effects.
Limitations: Abstract only; owner/vet scoring details unavailable.
- Species
- dog
- Participants / condition
- 78 client-owned dogs with hip or stifle osteoarthritis; 74 completed
- Formulation
- Triglyceride omega-3 oil (not anchovy-oil chew)
- Studied amount, not dosing advice
- Average 69 mg EPA+DHA per kg per day; label gives 110 mg total omega-3 per chew
- Duration
- 84 days
- Funding / conflicts
- Not reported in the abstract
Fish-oil food and weight bearing
Randomized, double-blinded, controlled trial · ingredient
Peak vertical force rose 5.6% versus 0.4% for control food (significant only in the test-food group); in the test-food group, vets' scores for lameness and weight bearing improved on day 90 compared with day 0.
Limitations: Whole-diet change; small sample; abstract only; the vet-score improvement was reported against baseline within the test-food group.
- Species
- dog
- Participants / condition
- 38 client-owned dogs with osteoarthritis
- Formulation
- Food with 3.5% fish oil omega-3 fatty acids, not a chew
- Studied amount, not dosing advice
- 3.5% of food; daily mg not reported
- Duration
- 90 days
- Funding / conflicts
- Not reported in the abstract
"Helps maintain comfortable movement and an active lifestyle at every life stage"
No evidence found
The trials found were in dogs with osteoarthritis or musculoskeletal signs. No applicable dog research on puppies from 12 weeks, healthy dogs, or this chew was retrieved.
Source: Advanced Joint Care Chew for Dogs: manufacturer product page →
Signals
- The page says 'Third-Party Tested: rigorously tested for quality' but shows no named test, lab or result for this product.
- 'Each ingredient is backed by extensive scientific research' outruns the sources reviewed: no dog MSM results were found, and glucosamine and chondroitin evidence is limited and conflicting.
- Label lists 110 mg total omega-3 per chew (9.7 to 55 mg/kg by size band), below the 69 mg/kg/day EPA+DHA studied in dogs.
- The '100,000+ five-star reviews' and 97% recommend figures are not clinical evidence, and the sample reviews shown mention a Probiotic Support Chew.
- Per-chew amounts are printed for glucosamine, MSM, mussel, chondroitin, omega-3, EPA, DHA and Boswellia.
- Weight-based chew numbers and a full composition list are published on the page.
- PetLab Co is on the NASC member list with the Quality Seal (checked 2026-11-03), a company-level audit and not a test of this chew.
Dose vs studies
Label amounts at the label's daily directions, per kg of body weight, compared with what dogs studies used. This compares the label with research. It is not dosing advice.
Label: 800 mg per chew
Studied: No established amount in dogs
Label: 500 mg per chew
Studied: No established amount in dogs
Label: 400 mg per chew
Studied: No established amount in dogs
Label: 300 mg per chew
Studied: No established amount in dogs
Label: 110 mg per chew · about 9.7-55 mg/kg/day
Studied: 69 mg/kg/day EPA+DHA
The label states Total Omega 3 Fatty Acids, not EPA+DHA. Even if all of it were EPA+DHA, it would be below the studied amount.
Label: 110 mg per chew · about 9.7-55 mg/kg/day
Studied: 69 mg/kg/day EPA+DHA
Evidence checks
Species and formulation relevance
All Evidence rows are dog results (cat results excluded), but none tested this chew. They used different mussel products, fish-oil foods, or combination supplements, often in dogs with diagnosed osteoarthritis. The 2022 meta-analysis (pmid36142319) pools dogs and cats and is cited as context only, not as a dog row. No trial in puppies or healthy dogs was retrieved.
Label transparency
Per-chew amounts and a dosing table by dog weight are printed. Omega-3 is stated as total, with EPA 70 mg and DHA 40 mg. Label amounts were not independently tested. Vet review is shown as one consultant quote only.
Independent quality testing
The page claims third-party testing without naming a test. NASC lists PetLab Co with its Quality Seal (company-level audit every two years plus random lab testing, checked 2026-11-03). NASC is a trade body, and the listing is not proof that this product was tested.
Dose comparison with research
Label omega-3 (110 mg per chew, 9.7 to 55 mg/kg by size band) is below the 69 mg/kg/day EPA+DHA studied in dogs. No dog reference amount was established for glucosamine, MSM, mussel or chondroitin. This is a comparison with research, not dosing advice.
Sources (13)
- 1. Advanced Joint Care Chew for Dogs: manufacturer product page →
Manufacturer · Accessed 2026-11-04
- 2. NASC member list, checked 2026-11-03 →
Quality standard · Accessed 2026-11-03
- 3. Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. →
Study · Accessed 2026-11-04
- 4. Glucosamine and chondroitin use in canines for osteoarthritis: A review. →
Research review · Accessed 2026-11-04
- 5. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. →
Research review · Accessed 2026-11-04
- 6. Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). →
Study · Accessed 2026-11-04
- 7. The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. →
Study · Accessed 2026-11-04
- 8. Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), <i>Biota orientalis</i> extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain: a blinded, placebo-controlled study. →
Study · Accessed 2026-11-04
- 9. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. →
Study · Accessed 2026-11-04
- 10. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. →
Study · Accessed 2026-11-04
- 11. Effects of a feed supplement, containing undenatured type II collagen (UC II®) and Boswellia Serrata, in the management of mild/moderate mobility disorders in dogs: A randomized, double-blind, placebo controlled, cross-over study. →
Study · Accessed 2026-11-04
- 12. Efficacy of a joint supplement containing eggshell membrane among other ingredients to improve the mobility of dogs with osteoarthritis: a multicenter double-blind randomized placebo-controlled study. →
Study · Accessed 2026-11-04
- 13. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. →
Study · Accessed 2026-11-04
How this report was produced
AI-assisted evidence analysis. We reviewed published material, not physical products.
Automated source and evidence checks completed on 2026-11-04. These checks are not veterinary review.
Research scope and outstanding checks
Searched Europe PMC-style queries on nutraceutical osteoarthritis systematic reviews in dogs, the product name, and Boswellia serrata in canine osteoarthritis. Many records were abstract-only, so methods, doses and funding were often unavailable. Not exhaustive. No exact-product trial found. Excluded as dog Evidence rows: human, rodent and cat results; the pooled dog-and-cat meta-analysis (context only). Mesotherapy, turmeric, collagen peptide and survey papers were not used as not relevant to these ingredients. The eggshell membrane supplement trial (pmid40530040) was used as a multi-ingredient Boswellia and krill omega-3 row. Manufacturer page and NASC list are not clinical evidence.
Focused research searches:
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (PetLabCo AND Joint AND Care AND Chew AND Advanced) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (PetLabCo AND Joint AND Care AND Chew AND Advanced) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (TITLE_ABS:Boswellia AND TITLE_ABS:serrata AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:Boswellia AND TITLE_ABS:serrata AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- Any trial of this exact chew
- Dog trials of MSM
- Boswellia dog studies at amounts comparable to 40 mg per chew
- Dog-only results from the pooled dog-and-cat meta-analysis on chondroitin-glucosamine
- Dog data for puppies or healthy dogs
- A named third-party test or lab report for this product
- Documentation of the vet review beyond one consultant quote